Novartis Pharmaceuticals Corporation Unclassified
FDA Approved Drugs

Novartis Pharmaceuticals Corporation Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified

Total Records 31
Latest Approval Date -
Data Source FDA
First Approval Date -

All

369

View

Unclassified

View

Discontinued

217

View

121

View

Company Overview

Company

Novartis Pharmaceuticals Corporation Unclassified

Country

Switzerland

Website

Visit Website

Social Profiles

Company Snapshot

Novartis Pharmaceuticals Corporation Unclassified

Klybeckstrasse 141, CH-4057, Basel

Switzerland

www.novartis.com/ View on Map

FDA Approved Drug Records ( 31 records )

Unclassified Application: 761128

Drug Name

ADAKVEO

Product Number

Dosage Form

Strength

100MG/10ML

Approval Date

761128 / 1 View Details

Active Ingredient

CRIZANLIZUMAB-TMCA

Application Number

761128

Product Number

Dosage Form

Strength

100MG/10ML

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 20927

Drug Name

AREDIA

Product Number

Dosage Form

Strength

30MG/VIAL

Approval Date

20927 / 1 View Details

Active Ingredient

PAMIDRONATE DISODIUM

Application Number

20927

Product Number

Dosage Form

Strength

30MG/VIAL

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 20927

Drug Name

AREDIA

Product Number

Dosage Form

Strength

60MG/VIAL

Approval Date

20927 / 2 View Details

Active Ingredient

PAMIDRONATE DISODIUM

Application Number

20927

Product Number

Dosage Form

Strength

60MG/VIAL

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 20927

Drug Name

AREDIA

Product Number

Dosage Form

Strength

90MG/VIAL

Approval Date

20927 / 3 View Details

Active Ingredient

PAMIDRONATE DISODIUM

Application Number

20927

Product Number

Dosage Form

Strength

90MG/VIAL

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 125326

Drug Name

ARZERRA

Product Number

Dosage Form

Strength

100MG/5ML

Approval Date

125326 / 1 View Details

Active Ingredient

OFATUMUMAB

Application Number

125326

Product Number

Dosage Form

Strength

100MG/5ML

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 761125

Drug Name

BEOVU

Product Number

Dosage Form

Strength

6MG/0.05ML

Approval Date

761125 / 1 View Details

Active Ingredient

brolucizumab-dbll

Application Number

761125

Product Number

Dosage Form

Strength

6MG/0.05ML

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 125504

Drug Name

COSENTYX

Product Number

Dosage Form

Strength

150MG/ML

Approval Date

125504 / 1 View Details

Active Ingredient

SECUKINUMAB

Application Number

125504

Product Number

Dosage Form

Strength

150MG/ML

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 761349

Drug Name

COSENTYX

Product Number

Dosage Form

Strength

150MG

Approval Date

761349 / 1 View Details

Active Ingredient

SECUKINUMAB

Application Number

761349

Product Number

Dosage Form

Strength

150MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 21279

Drug Name

FORADIL

Product Number

Dosage Form

Strength

0.012MG/INH

Approval Date

21279 / 1 View Details

Active Ingredient

FORMOTEROL FUMARATE

Application Number

21279

Product Number

Dosage Form

Strength

0.012MG/INH

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 125319

Drug Name

ILARIS

Product Number

Dosage Form

Strength

180MG

Approval Date

125319 / 1 View Details

Active Ingredient

CANAKINUMAB

Application Number

125319

Product Number

Dosage Form

Strength

180MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 125326

Drug Name

KESIMPTA

Product Number

Dosage Form

Strength

20MG/0.4ML

Approval Date

125326 / 2 View Details

Active Ingredient

OFATUMUMAB

Application Number

125326

Product Number

Dosage Form

Strength

20MG/0.4ML

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 217513

Drug Name

MEKINIST

Product Number

Dosage Form

Strength

2MG

Approval Date

217513 / 2 View Details

Active Ingredient

TRAMETINIB

Application Number

217513

Product Number

Dosage Form

Strength

2MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 217513

Drug Name

MEKINIST

Product Number

Dosage Form

Strength

4.7MG

Approval Date

217513 / 3 View Details

Active Ingredient

TRAMETINIB

Application Number

217513

Product Number

Dosage Form

Strength

4.7MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 50735

Drug Name

NEORAL

Product Number

Dosage Form

Strength

25MG

Approval Date

50735 / 1 View Details

Active Ingredient

CYCLOSPORINE

Application Number

50735

Product Number

Dosage Form

Strength

25MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 50735

Drug Name

NEORAL

Product Number

Dosage Form

Strength

100MG

Approval Date

50735 / 2 View Details

Active Ingredient

CYCLOSPORINE

Application Number

50735

Product Number

Dosage Form

Strength

100MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 50736

Drug Name

NEORAL

Product Number

Dosage Form

Strength

25MG

Approval Date

50736 / 1 View Details

Active Ingredient

CYCLOSPORINE

Application Number

50736

Product Number

Dosage Form

Strength

25MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 50736

Drug Name

NEORAL

Product Number

Dosage Form

Strength

100MG

Approval Date

50736 / 2 View Details

Active Ingredient

CYCLOSPORINE

Application Number

50736

Product Number

Dosage Form

Strength

100MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 50737

Drug Name

NEORAL

Product Number

Dosage Form

Strength

25MG

Approval Date

50737 / 1 View Details

Active Ingredient

CYCLOSPORINE

Application Number

50737

Product Number

Dosage Form

Strength

25MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 50737

Drug Name

NEORAL

Product Number

Dosage Form

Strength

100MG

Approval Date

50737 / 2 View Details

Active Ingredient

CYCLOSPORINE

Application Number

50737

Product Number

Dosage Form

Strength

100MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 50738

Drug Name

NEORAL

Product Number

Dosage Form

Strength

25MG

Approval Date

50738 / 1 View Details

Active Ingredient

CYCLOSPORINE

Application Number

50738

Product Number

Dosage Form

Strength

25MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 50738

Drug Name

NEORAL

Product Number

Dosage Form

Strength

100MG

Approval Date

50738 / 2 View Details

Active Ingredient

CYCLOSPORINE

Application Number

50738

Product Number

Dosage Form

Strength

100MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 103764

Drug Name

SIMULECT

Product Number

Dosage Form

Strength

10MG

Approval Date

103764 / 1 View Details

Active Ingredient

BASILIXIMAB

Application Number

103764

Product Number

Dosage Form

Strength

10MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 103764

Drug Name

SIMULECT

Product Number

Dosage Form

Strength

20MG

Approval Date

103764 / 2 View Details

Active Ingredient

BASILIXIMAB

Application Number

103764

Product Number

Dosage Form

Strength

20MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 217514

Drug Name

TAFINLAR

Product Number

Dosage Form

Strength

75MG

Approval Date

217514 / 2 View Details

Active Ingredient

DABRAFENIB MESYLATE

Application Number

217514

Product Number

Dosage Form

Strength

75MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 217514

Drug Name

TAFINLAR

Product Number

Dosage Form

Strength

10MG

Approval Date

217514 / 3 View Details

Active Ingredient

DABRAFENIB MESYLATE

Application Number

217514

Product Number

Dosage Form

Strength

10MG

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 21167

Drug Name

VIVELLE

Product Number

Dosage Form

Strength

0.0375MG/24HR

Approval Date

21167 / 1 View Details

Active Ingredient

ESTRADIOL

Application Number

21167

Product Number

Dosage Form

Strength

0.0375MG/24HR

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 21167

Drug Name

VIVELLE

Product Number

Dosage Form

Strength

0.05MG/24HR

Approval Date

21167 / 2 View Details

Active Ingredient

ESTRADIOL

Application Number

21167

Product Number

Dosage Form

Strength

0.05MG/24HR

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 21167

Drug Name

VIVELLE

Product Number

Dosage Form

Strength

0.075MG/24HR

Approval Date

21167 / 3 View Details

Active Ingredient

ESTRADIOL

Application Number

21167

Product Number

Dosage Form

Strength

0.075MG/24HR

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 21167

Drug Name

VIVELLE

Product Number

Dosage Form

Strength

0.1MG/24HR

Approval Date

21167 / 4 View Details

Active Ingredient

ESTRADIOL

Application Number

21167

Product Number

Dosage Form

Strength

0.1MG/24HR

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 21167

Drug Name

VIVELLE

Product Number

Dosage Form

Strength

0.025MG/24HR

Approval Date

21167 / 5 View Details

Active Ingredient

ESTRADIOL

Application Number

21167

Product Number

Dosage Form

Strength

0.025MG/24HR

Approval Date

Regulatory Status

Unclassified

Unclassified Application: 21386

Drug Name

ZOMETA

Product Number

Dosage Form

Strength

EQ 4MG BASE/VIAL

Approval Date

21386 / 1 View Details

Active Ingredient

ZOLEDRONIC ACID

Application Number

21386

Product Number

Dosage Form

Strength

EQ 4MG BASE/VIAL

Approval Date

Regulatory Status

Unclassified

Related Databases

FDA Inspections
74 View
EDQM CEP
3 View
KDMF
0 View
Japan DMF
2 View
Eudra GMP
0 View
NDC Database
80 View
FDA Approved Drugs Database
369 View
Drug Prices in Switzerland
0 View

Drug Status Breakdown

31 total

Unclassified

Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book

FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ADAKVEO

Application Number

761128

Product Number

Active Ingredient

CRIZANLIZUMAB-TMCA

Dosage Form

Strength

100MG/10ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Required Quantity *

Please enter quantity.

Measurement Unit *

Please select a unit.

Quality Standard *

Please select quality standard.

Request Type *

Please select request type.

Product Specifications *

Please provide product specifications.

Additional Details *

Please enter additional details.

Shipping Preference *

Please select shipping preference.

Expected Delivery Date

Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.